ESCRS - FP27.13 - Phase 2A Multicenter Clinical Trial To Determine The Feasibility And Safety Of The Use Of Adipose-Derived Mesenchymal Stem Cells (Asc( In The Treatment Of Patients With Cicatricial Conjunctivitis

Phase 2A Multicenter Clinical Trial To Determine The Feasibility And Safety Of The Use Of Adipose-Derived Mesenchymal Stem Cells (Asc( In The Treatment Of Patients With Cicatricial Conjunctivitis

Published 2025 - 43rd Congress of the ESCRS

Reference: FP27.13 | Type: Free paper | DOI: 10.82333/9x42-c310